Hemangi Panchmatia, MSc

Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder

This retrospective analysis of administrative claims data compared healthcare resource utilization 6 months before and after initiating a combination of olanzapine and samidorphan (OLZ/SA...

Hemangi Panchmatia , MSc;

10/26/2023

Burden of Bipolar I Disorder on Clinical, Economic, and Humanistic Outcomes: Matched Analysis of US National Health and Wellness Survey Data

Patients with bipolar I disorder (BD-I) have an increased risk of obesity. This analysis assessed real-world outcomes in patients with BD-I vs controls using 2016/2020 National Health and...

Hemangi Panchmatia , MSc;

10/26/2023